Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Mcalinden (Sydney, Australia), A. Kota (Sydney, Australia), B. Oliver (Sydney, Australia), M. Haghi (Sydney, Australia), P. Sharma (Sydney, Australia). Selective activation and targeting of autophagy in severe asthma.. 5251

Member's Comments

No comment yet.

Related content which might interest you: Induced sputum differential gene expression implicates increased p38 signalling activity in severe asthma Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease Year: 2011 Selective decoy-mediated inhibition of activator protein-1 activity in the airways prevents experimental asthmatic inflammation Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response Year: 2005 Inhibition of VEGF blocks the activation of TGF-β1 through a PI3K/Akt signaling pathway in allergic airway disease of mice Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007 Inhibition of uPA-uPAR signaling restores respiratory epithelial barrier function in asthma and COPD Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Dual mechanism of action of T2 inhibitor therapies in virally induced exacerbations of asthma: evidence for a beneficial counter-regulation Source: Eur Respir J, 54 (1) 1802390; 10.1183/13993003.02390-2018 Year: 2019 Targeting the mTOR signaling pathway to inhibit lung cell senescence in chronic obstructive pulmonary disease (COPD) Source: ERS Lung Science Conference 2017 Year: 2017 Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma Source: Eur Respir J 2010; 35: 750-756 Year: 2010 Inhibition of the alternative complement pathway abolishes the development of airway hyperresponsiveness (AHR) and inflammation Source: Eur Respir J 2004; 24: Suppl. 48, 348s Year: 2004 Nrf2-regulated chaperon-mediated autophagy is involved in apoptosis modulation in COPD pathogenesis. Source: Virtual Congress 2020 – Cellular stress in respiratory diseases Year: 2020 Chaperone-mediated autophagy modulates epithelial cell apoptosis in COPD pathogenesis. Source: International Congress 2019 – Effects of environmental exposures in lung pathology and the underlying mechanisms Year: 2019 TGFβ overproduction in asthma reduces the epithelial repair by down-regulating the leptin/leptin receptor pathway Source: Eur Respir J 2007; 30: Suppl. 51, 59s Year: 2007 Anti-inflammatory effect of hypoxic signaling suppression in the severe COPD model. Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium Year: 2018 A role for WNT-5B in airway remodeling in COPD by activation of TGF-beta/Smad3 signaling? Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Treatment with Omalizumab in adults with severe allergic reduces Fc?I expression on dendritic cells and improves antiviral responses. Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Inhibition of Pim1 kinase, new therapeutic approach in virus-induced asthma exacerbations Source: Eur Respir J 2016; 47: 783-791 Year: 2016 Rapamycin protects OVA induced asthma in mice through regulating autophagy Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Oxidative stress-induced corticosteroid insensitivity is reversed by formoterol via inhibition of PI3K signalling in peripheral blood mononuclear cells from patients with COPD and severe asthma Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011 Inhibition of phosphodiesterase 4B enhances glucocorticoid-dependent gene transcription in human airway epithelial cells: Implications for the treatment of COPD Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 Cigarette-decreased NAD/SIRT1 aggravates pulmonary fibrosis by promoting senescence of alveolar type 2 cells through autophagy inhibition and mitochondrial oxidative stress induction Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Dual aVß6/aVß1 inhibitor PLN-74809 blocks multiple TGF-ß activation pathways associated with IPF Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019